Popular search terms:
Report An Undesirable Effect
Contact information for reporting an Undesirable Effect relating to one of our treatments.
View Contact Information on CSL.comSearch Results
33 results found-
Our Australian offices are in Melbourne, Victoria, Australia
https://www.cslbehring.com.au/contact-us -
Social Media Community Guidelines for CSL Behring Corporate Channels
https://www.cslbehring.com.au/social-guidelines -
CSL is committed to providing information in a way that is accessible and understandable for all, regardless of any disability.
https://www.cslbehring.com.au/accessibility-statement -
Learn more about the CSL Behring Broadmeadows Community Grant.
https://www.cslbehring.com.au/our-company/the-csl-behring-commitment/csl-behring-community-grant/how-to-apply -
Our partnering approach is to structure deals that leverage the value of CSL Behring’s world-class R&D, commercial and manufacturing operations.
https://www.cslbehring.com.au/partnering -
contact your doctor, or about side effects.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/andembry-pf-pen-cmi-200.pdf -
The reagents used in the aPTT laboratory test initiate intrinsic coagulation through the activation of FXII in the contact system, therefore inhibition of plasma FXIIa by garadacimab can prolong aPTT in this assay.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/andembry-pi-200.pdf